PRESS RELEASE published on 12/17/2025 at 09:30, 8 months 10 days ago Topadur Appoints Matthias Schäfer as Chief Executive Officer to Lead Next Phase of Company Growth Topadur Pharma AG appoints Matthias Schäfer as Chief Executive Officer to lead company growth into next phase of clinical development and expansion. Dr. Reto Naef transitions to Senior Scientific Advisor Clinical Development Chief Executive Officer Topadur Pharma AG Matthias Schäfer Scientific Advisor
PRESS RELEASE published on 12/17/2025 at 09:30, 8 months 10 days ago Designated Person Notification Aperam announces Designated Person Notification regarding share transactions as per Market Abuse Regulations. Aperam is a global stainless steel player committed to the circular economy Share Transactions Market Abuse Regulations Aperam Circular Economy Designated Person Notification
PRESS RELEASE published on 12/17/2025 at 09:21, 8 months 10 days ago Heidelberg Pharma: Letter from the CEO Heidelberg Pharma CEO addresses delays in milestone payment, emphasizing continued development of TLX250-CDx and promising phase I study results for pamlectabart tismanitin (HDP-101). Financial challenges are being addressed proactively CEO Heidelberg Pharma Milestone Payment TLX250-CDx Pamlectabart Tismanitin
PRESS RELEASE published on 12/17/2025 at 09:05, 8 months 10 days ago Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology Norgine enhances hepatology and specialty portfolio by in-licensing Vir Biotechnology's chronic hepatitis delta treatment for Europe, Australia, and New Zealand Exclusive Licensing Agreement Specialty Pharmaceuticals Norgine Vir Biotechnology Chronic Hepatitis Delta Treatment
PRESS RELEASE published on 12/17/2025 at 09:05, 8 months 10 days ago Over 40% of Adults Struggle to Swallow Pills - BioNxt Targets a Global Adherence Problem with Rapid-Dissolving Thin-Film “Melt-in-Your-Mouth” Therapies BioNxt Solutions Inc. announces breakthrough in drug delivery for dysphagia, securing first national-level patent for thin-film platform, targeting autoimmune markets with bioequivalent cladribine treatment BioNxt Solutions Inc. Drug Delivery Dysphagia Thin-film Platform Autoimmune Markets
PRESS RELEASE published on 12/17/2025 at 09:00, 8 months 10 days ago Financial Conduct Authority: Financial Conduct Authority admits multiple securities to the Official List on 17-Dec-2025, including shares, ETFs, and debt-like securities from various issuers Securities Financial Conduct Authority Official List Issuers Debt-like Securities
PRESS RELEASE published on 12/17/2025 at 09:00, 8 months 10 days ago Removal- Diversity Funding No. 1 Limited Financial Conduct Authority removes Diversity Funding No. 1 Limited securities from the Official List on 17/12/2025, 08:00 GMT. Debt-like securities delisted Securities Financial Conduct Authority Official List Debt-like Securities Diversity Funding No. 1 Limited
PRESS RELEASE published on 12/17/2025 at 08:30, 8 months 10 days ago Neo Energy Metals plc - Restoration The Financial Conduct Authority restores Neo Energy Metals plc to the Official List, effective from 17/12/2025, 07:30 GMT/BST Financial Conduct Authority Equity Shares Restoration Official List Neo Energy Metals Plc
PRESS RELEASE published on 12/17/2025 at 08:30, 8 months 10 days ago GLOBAL ESG MONITOR 2025: MATERIALITY ANALYSIS WIDELY ADOPTED – INTEGRATION INTO RISIK MANAGEMENT SHOWS GAPS Global ESG Monitor 2025 reveals gaps in integrating materiality analysis into risk management among DAX companies, showcasing discrepancies with stakeholder expectations Risk Management ESG Materiality Analysis DAX Companies Stakeholder Expectations
PRESS RELEASE published on 12/17/2025 at 08:30, 8 months 10 days ago Aquis Stock Exchange: Suspension from trading Valereum Plc's Ordinary Shares (Symbol: VLRM, ISIN: GI000A2P2W41) suspended from trading on Aquis Stock Exchange's Growth Market as of 17th Dec 2025 08:00 GMT/BST Ordinary Shares Trading Aquis Stock Exchange Suspension Valereum Plc
Published on 08/27/2026 at 14:00, 44 minutes ago QNX and Hailo Join Forces to Advance Reliable Physical AI at the Edge
Published on 08/27/2026 at 13:45, 59 minutes ago Electric Royalties Reports Operating Growth and Broad Advancement Across Critical Metals Royalty Portfolio
Published on 08/27/2026 at 13:30, 1 hour 14 minutes ago AirIQ Announces June 30, 2026 Quarterly Results
Published on 08/27/2026 at 13:30, 1 hour 14 minutes ago Stillwater Critical Minerals More Than Doubles Stillwater West Inferred Mineral Resource and Establishes Maiden Indicated Resource
Published on 08/27/2026 at 13:30, 1 hour 14 minutes ago Critical Elements Hires Director of Investor Relations and Communications
Published on 08/27/2026 at 14:29, 15 minutes ago EQS-Adhoc: BOS GmbH & Co. KG to Publish Q2 2026 Interim Results on 31 August 2026 and Revises FY 2026 Guidance
Published on 08/27/2026 at 12:17, 2 hours 27 minutes ago AUSTRIACARD HOLDINGS AG: DNP’s Voluntary Takeover Offer: Update on the separate tradability request
Published on 08/26/2026 at 18:02, 20 hours 42 minutes ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:00, 20 hours 44 minutes ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/25/2026 at 17:45, 1 day 20 hours ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 08/25/2026 at 17:45, 1 day 20 hours ago Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026